Genovate Biotechnology Valuation
| 4130 Stock | TWD 23.95 0.25 1.05% |
At this time, the firm appears to be fairly valued. Genovate Biotechnology retains a regular Real Value of NT$23.48 per share. The prevalent price of the firm is NT$23.95. Our model calculates the value of Genovate Biotechnology from evaluating the firm fundamentals such as Current Valuation of 3.16 B, return on equity of 0.0022, and Return On Asset of 0.0015 as well as inspecting its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Genovate Biotechnology's price fluctuation is very steady at this time. Calculation of the real value of Genovate Biotechnology is based on 3 months time horizon. Increasing Genovate Biotechnology's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Genovate stock is determined by what a typical buyer is willing to pay for full or partial control of Genovate Biotechnology Co. Since Genovate Biotechnology is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Genovate Stock. However, Genovate Biotechnology's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 23.95 | Real 23.48 | Hype 23.95 |
The intrinsic value of Genovate Biotechnology's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Genovate Biotechnology's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Genovate Biotechnology Co helps investors to forecast how Genovate stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Genovate Biotechnology more accurately as focusing exclusively on Genovate Biotechnology's fundamentals will not take into account other important factors: Genovate Biotechnology Total Value Analysis
Genovate Biotechnology Co is presently anticipated to have takeover price of 3.16 B with market capitalization of 3.3 B, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Genovate Biotechnology fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.16 B | 3.3 B |
Genovate Biotechnology Investor Information
About 27.0% of the company shares are owned by institutions such as pension funds. The book value of Genovate Biotechnology was presently reported as 12.82. The company last dividend was issued on the 20th of July 2022. Genovate Biotechnology had 1000:1030 split on the 20th of August 2024. Based on the key measurements obtained from Genovate Biotechnology's financial statements, Genovate Biotechnology Co is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Genovate Biotechnology Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Genovate indicates not a very effective usage of assets in January.Genovate Biotechnology Ownership Allocation
Genovate Biotechnology Co has a total of 109.38 Million outstanding shares. Genovate Biotechnology retains 3.95 (percent) of its outstanding shares held by insiders and 26.96 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Genovate Biotechnology Profitability Analysis
The company reported the revenue of 434.25 M. Net Income was 372 K with profit before overhead, payroll, taxes, and interest of 149.75 M.About Genovate Biotechnology Valuation
Our relative valuation model uses a comparative analysis of Genovate Biotechnology. We calculate exposure to Genovate Biotechnology's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Genovate Biotechnology's related companies.8 Steps to conduct Genovate Biotechnology's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Genovate Biotechnology's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Genovate Biotechnology's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Genovate Biotechnology's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Genovate Biotechnology's revenue streams: Identify Genovate Biotechnology's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Genovate Biotechnology's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Genovate Biotechnology's growth potential: Evaluate Genovate Biotechnology's management, business model, and growth potential.
- Determine Genovate Biotechnology's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Genovate Biotechnology's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Genovate Stock Analysis
When running Genovate Biotechnology's price analysis, check to measure Genovate Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genovate Biotechnology is operating at the current time. Most of Genovate Biotechnology's value examination focuses on studying past and present price action to predict the probability of Genovate Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genovate Biotechnology's price. Additionally, you may evaluate how the addition of Genovate Biotechnology to your portfolios can decrease your overall portfolio volatility.